From: Current status of Staphylococcus aureus infection in a central teaching hospital in Shanghai, China
STs | % (No./total) | MRSA/MSSA |
---|---|---|
qacA/B (+) | ||
ST239 | 18.8% (38/202) | 100.0% (38/38) |
ST5 | 15.2% (28/184) | 96.4% (27/28) |
ST6 | 6.3% (1/16) | 0/1 |
ST7 | 3.7% (1/27) | 0/1 |
ST20a | 1/5 | 0/1 |
ST22 | 1/2 | 0/1 |
ST1821 | 1/4 | 0/1 |
ST359 | 1/1 | 0/1 |
pvl (+) | ||
ST398 | 26.7% (4/15) | 0/4 |
ST88 | 20.0% (2/10) | 0/2 |
ST59 | 5.9% (1/17) | 1/0 |
ST7 | 3.7% (1/27) | 1/0 |
ST338 | 1/1 | 0/1 |
ST22 | 1/2 | 0/1 |
muPA (+) | ||
ST1 | 65.6% (21/32) | 100% (21/21) |
ST630 | 16.7% (2/12) | 0/2 |
ST398 | 13.3% (2/15) | 0/2 |
ST59 | 11.8% (2/17) | 2/0 |
ST5 | 10.9% (20/184) | 100.0% (20/20) |
ST7 | 7.4% (2/27) | 0/2 |
ST680 | 5.6% (1/18) | 1/0 |
ST188 | 4.8% (1/21) | 0/1 |
ST239 | 3.5% (7/202) | 7/0 |
ST1036 | 1/2 | 0/1 |
ST121 | 1/1 | 0/1 |